跳至主要内容
临床试验/NCT01167218
NCT01167218已完成不适用

"In-vitro Characterization of Platelet Dysfunction in Common Hematological Disorders Using the Verify Now Assay"

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
79
试验地点
1
主要终点
platelet aggregation defects

研究概览

简要总结

The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).

详细描述

Verify Now is a rapid, simple, point-of service assay to measure platelet aggregation. The verify now assay is designed to assess platelet function based on the ability of activated platelets to bind fibrinogen. It is hoped that this study will detect the subtle platelet functional abnormalities in patients with hematological disorders.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

platelet aggregation defects

时间窗: one year

to assess platelet aggregation defects

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study to Assess Platelet Dysfunction With Verify Now... | 临床试验